Jacobus P.
- Country
- The Netherlands
- Department
- Cardiologie
Research Overview
- Phase 3 Randomized Study Comparing Asundexian and Apixaban for Stroke Prevention in Atrial Fibrillation Patients at Risk
- A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impactof Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME-CV)
- A Double-blind, Randomized, Placebo-controlled, Multi-center Study Evaluating the Safety, Tolerability, and Effect of Olpasiran on Coronary Artery Plaque Burden Assessed by Coronary Computed Tomography Angiography in Participants With Stable Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a)
Data & Insights
Has run more than one trial at 118 of 648 partner sites.
Specializations
Cardiovascular Medicine
The investigator specializes in the clinical research of stroke prevention and atrial fibrillation management, with particular focus on innovative therapeutic approaches in cardiovascular medicine.
- Stroke Prevention Strategies
- Atrial Fibrillation Management
- Systemic Embolism Prevention
Their work encompasses the evaluation of novel anticoagulation therapies for patients with cardiac arrhythmias.
Thrombosis Research
The investigator focuses on advancing thrombosis prevention methodologies, particularly in the context of cardiac conditions and their complications.
- Anticoagulation Therapies
- Bleeding Risk Assessment
- Therapeutic Safety Profiles
Their research extends to evaluating the efficacy and safety profiles of new anticoagulant medications.
Clinical Cardiology
The investigator's expertise includes the study of cardiac arrhythmias and their relationship to thromboembolic events.
- Cardiac Rhythm Management
- Cardiovascular Risk Assessment
- Preventive Cardiology
Their clinical interests encompass the development of preventive strategies for high-risk cardiac patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.